Indian Scientists Rewrite a Fundamental Rule of Bacterial Biology, Opening New Frontiers in TB Treatment

The study challenges the notion of a “one-size-fits-all” mechanism in bacterial transcription and highlights the diversity of regulatory strategies employed by pathogens.

In a breakthrough that challenges decades-old molecular biology doctrine, a team of scientists from the Bose Institute, Kolkata, has uncovered a critical flaw in the long-accepted model of bacterial gene regulation—an advance that could pave the way for next-generation therapies against tuberculosis (TB) and other drug-resistant infections.

Published in the prestigious international journal Nucleic Acids Research, the study overturns the long-standing belief in the “universal σ-cycle”—a foundational concept taught in biology textbooks worldwide—and introduces a more complex, nuanced understanding of how bacteria control gene expression under stress.

Rethinking a “Universal” Rule in Biology

For decades, scientists have believed that σ (sigma) factors—proteins essential for initiating transcription in bacteria—bind to RNA polymerase to start gene expression and are subsequently released once RNA synthesis begins. This cyclical binding-and-release mechanism, known as the σ-cycle, was considered universal across bacterial species.

However, researchers Dr. Jayanta Mukhopadhyay and Dr. N. Hazra have now demonstrated that this model does not universally apply—particularly in Mycobacterium tuberculosis, the pathogen responsible for TB.

Their findings reveal that while some σ factors detach during transcription, others remain firmly bound to RNA polymerase throughout the process, indicating the existence of multiple regulatory strategies rather than a single, uniform mechanism.

A Breakthrough in Understanding TB Survival

Tuberculosis remains one of the deadliest infectious diseases globally, responsible for over 10 million cases and approximately 1.3 million deaths annually, according to recent global health estimates. The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) TB strains has further complicated treatment efforts, making the need for novel therapeutic strategies urgent.

The ability of M. tuberculosis to survive within the human host—often for years in a latent state—is largely attributed to its sophisticated gene regulation under extreme stress conditions such as hypoxia, immune pressure, and nutrient deprivation.

This new study provides unprecedented insight into how the bacterium achieves this.

Differential Behavior of Sigma Factors

The research focused on three key σ factors:

• σA – the primary housekeeping σ factor responsible for routine cellular functions

• σE – a stress-responsive σ factor activated under hostile conditions

• σF – associated with long-term stress survival and bacterial persistence

Using a combination of advanced experimental approaches—including in vitro transcription assays, fluorescence-based measurements, high-resolution protein interaction studies, and in vivo chromatin immunoprecipitation followed by quantitative PCR—the team uncovered striking differences in how these σ factors behave:

• σA and σE were found to dissociate from RNA polymerase during transcription elongation—either immediately or progressively

• σF, in contrast, remained tightly bound to RNA polymerase throughout transcription

This stable association of σF suggests a previously unknown mechanism that enables continuous activation of stress-response genes—critical for the bacterium’s survival inside the host.

From Basic Science to Drug Discovery

The implications of this discovery extend far beyond academic interest. By demonstrating that σ–RNA polymerase interactions vary depending on the structural and functional properties of σ factors, the study identifies a new class of highly specific drug targets.

Traditional antibiotics often target enzyme active sites, which can mutate over time, leading to resistance. In contrast, disrupting protein–protein interactions—such as those between σ factors and RNA polymerase—offers a more precise and potentially more durable therapeutic strategy.

This approach could be particularly effective against TB, where resistance to frontline drugs like rifampicin and isoniazid continues to rise.

A Paradigm Shift in Molecular Biology

The study challenges the notion of a “one-size-fits-all” mechanism in bacterial transcription and highlights the diversity of regulatory strategies employed by pathogens. It underscores the importance of revisiting established biological models in light of new evidence, especially in the era of precision medicine and molecular targeting.

“This work fundamentally changes how we think about bacterial gene regulation,” researchers noted, emphasizing that textbook models may need revision to accommodate organism-specific variations.

Strategic Importance for Global Health

With antimicrobial resistance (AMR) projected to cause up to 10 million deaths annually by 2050 if left unchecked, discoveries like this are critical. They not only deepen scientific understanding but also provide actionable insights for developing innovative therapeutics.

India, which bears one of the highest burdens of TB globally, stands to benefit significantly from such homegrown research breakthroughs. Institutions like the Bose Institute, under the Department of Science and Technology (DST), continue to play a pivotal role in advancing cutting-edge biomedical research aligned with national and global health priorities.

Looking Ahead

The discovery of non-uniform σ-factor behavior opens new avenues for:

• Designing targeted antimicrobial therapies

• Understanding bacterial persistence and latency mechanisms

• Developing precision interventions against drug-resistant infections

As the global scientific community intensifies efforts to combat infectious diseases, this breakthrough marks a significant step toward smarter, more targeted approaches to bacterial control.